in India

Lupin shares in focus as USFDA inspection at Somerset facility concludes with no observations

140 Views

Lupin share price will remain in focus on Monday, February 3, as the company received no observation from the United States Food and Drug Administration (USFDA) post completion of pre-approval inspection.

“Global pharma major Lupin Limited today announced that the United States Food and Drug…

Read More

What do you think?

0 Points
Upvote Downvote

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Making health system push economic growth: a case of missed opportunity

capex theme | consumption theme: Budget 2025 has given a signal that govt cares for the middle class, for consumption: Hiren Ved